Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Knight Therapeutics Inc T.GUD

Alternate Symbol(s):  KHTRF

Knight Therapeutics Inc. is a specialty pharmaceutical company. The Company’s principal business activity is developing, acquiring, in-licensing, out-licensing, manufacturing, marketing and distributing pharmaceutical products in Canada, Latin America and select international markets. It finances other life sciences companies and secures product distribution rights for Canada and select... see more

TSX:GUD - Post Discussion

Knight Therapeutics Inc > It warms the cockles of my heart ...
View:
Post by MrMugsy on Jun 10, 2022 11:25am

It warms the cockles of my heart ...

It warms the cockles of my heart to see ENDO's stock price at almost zero.

Not because I wish them any harm ... but ... it's about time that the market sees them for what they really are - for all the mistakes they made.  Funny that investors were proping this thing up for years yet there was no basis for doing that.  The troubles were obvious and the real pain is yet to come.

Well - it gave invested shareholders more than enough time to exit and limiting their losses while others were left to hold the bag.  What a soap opera.  Looking forward to the restructuring to see how that plays out - think discussions are well underway.

I still remember when Goodman made comment to Endo's debt-laden approach and how it would eventually hurt them.  Still rings loud in my ear.

And so here we are ... man ... I think Endo's CEO learned early not to like Goodman for that honesty.  Hahaha!  Just love it !!!!
Comment by longrun86 on Jun 10, 2022 6:31pm
It's not just Endo... look at the clowns who were running Bausch Health (Valeant). The too have destoryed the majority of shareholders equity. Debt is like booze. In the begginning it tastes and feels good... but too much and you lose it all. Mix that in with bad business practices and you have the makings of a fine country song! Happy weekend all! LR
Comment by MrMugsy on Jun 10, 2022 8:56pm
Right - thought that was still around $30/share ... didn't realize it dropped to $8 (with more than $23B in debt)
Comment by Chianchin on Jun 11, 2022 7:47am
About at GUD 1 billion cash, $10.50 share price? Now mostly evaporated
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities